Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will be conducted in a randomized controlled experimental design to examine the effects of acupressure applied to patients treated in the intensive care unit on physiological parameters, pain, sleep quality, anxiety and perception of nurse presence. The study will be conducted with 60 patients (20 intervention, 20 placebo, 20 control groups) treated in the 2nd stage Intensive Care Unit of an University Hospital between May 2025 and January 2026. Acupressure will be applied to the intervention group for 2 days, morning and evening, for four sessions. For four sessions, pseudo acupressure will be used on the placebo group for 2 days, morning and evening. No application will be made to the control group. The data collection tools in the study are the Patient Identifier Information Form, Glasgow Coma Scale (GCS), Visual Assessment Scale (VAS), Physiological Parameter Assessment Form, Richards-Campbell Sleep Scale, Spielberg State-Trait Anxiety Inventory, and Nurse Presence Scale (PONS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedMarch 19, 2026
March 1, 2026
8 months
May 20, 2025
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Visual Assessment Scale
VAS is a measurement tool frequently used in the clinic for pain assessment. The ruler, which is indicated as 0-10 cm or 0-100 mm, has no pain (0) written on one end and the most severe pain (10) on the other end. It is scored between 0-10. The patient marks the point on the ruler where he feels the pain.
1st day and second day- morning and evening; 15 minutes before application and 30 minutes after the application
Spielberg State-Trait Anxiety Scale
The scale consists of two sub-dimensions measuring continuous and state anxiety. There are 20 questions for each sub-dimension on a 4-point Likert scale (not at all = 1, a little = 2, a lot = 3, completely = 4). The minimum-maximum score range that can be obtained from the scale varies between 20-80. Increasing scores on the scale indicate an increase in the level of anxiety.
1st day and second day- morning and evening; 15 minutes before application and 30 minutes after the application and third day morning.
Physiological Parameters Assessment Form
Systolic Blood Pressure (mm/Hg), Diastolic Blood Pressure (mm/Hg), Respiratory Rate, Heart Rate (Pulse) (beats/min) and Saturation parameters measured before and after acupressure of the intervention and placebo groups will be recorded. Systolic blood pressure measurements will be averaged. Diastolic blood pressure measurements will be averaged. Saturation measurements will be averaged. Respiratory rate measurements will be averaged. Heart Rate (Pulse) measurements will be averaged.
1st day and second day- morning and evening; 15 minutes before application and 30 minutes after the application
Nursing Presence Scale
The scale designed as a 5-point Likert is scored as follows; (never: 1 point), (rarely: 2 points), (occasionally/sometimes: 3 points), (frequently: 4 points) and (always: 5 points). The minimum and maximum scores that can be obtained from the scale are calculated between 24-120. An increase in the score obtained from the scale means that the behaviors in which the patient presents the presence of the nurse have increased and that the patient perceives these behaviors positively.
1st day 15 minutes before application and third day morning.
Secondary Outcomes (1)
Richards-Campbell Sleep Scale
1st day and second day- morning and evening; 15 minutes before application and 30 minutes after the application and third day morning.
Study Arms (3)
Application group
EXPERIMENTALAfter the purpose of the study and the method of application are explained to the intensive care patients, the "Introductory Information Form", "Glasgow Coma Scale", "Visual Assessment Scale", "Physiological Parameters Assessment Form", "Richards-Campbell Sleep Scale", "Nursing Presence Scale" and "Spielberg State-Trait Anxiety Scale" will be applied. A total of 8 sessions of acupressure will be applied morning and evening for 2 days. The measurements will be repeated afterwards.
Placebo Group
PLACEBO COMPARATORAfter the purpose of the study and the method of application are explained to the intensive care patients, the "Introductory Information Form", "Glasgow Coma Scale", "Visual Assessment Scale", "Physiological Parameters Assessment Form", "Richards-Campbell Sleep Scale", "Nursing Presence Scale" and "Spielberg State-Trait Anxiety Scale" will be applied. A total of 8 sessions of pseudo acupressure will be applied morning and evening for 2 days. Only light pressure will be applied without massage 2 cm to the side of the real points. The procedure will be performed with gloves. The measurements will be repeated afterwards.
Control Group
NO INTERVENTIONNo application will be made to the control group.
Interventions
The patient will be placed in a suitable position (supine) or alternatively in a side-lying position, and the patient's privacy will be taken into account to determine the pressure points. The patient's own finger measurement will be taken into account when determining the pressure points. Acupressure points will be marked using a surgical marking pen. The pressure will be applied manually. The thumb will be used for this. Before applying direct pressure to the point, a light rubbing movement will be made for approximately 15 seconds on the point area to reduce tension and tissue sensitivity, to warm, relax and prepare. Approximately 2 minutes of pressure will be applied to each point in a circular manner. Each application will last approximately 18 minutes. The patient will be measured 9 times in total during 4 sessions.
A pseudo acupressure will be applied to the patients in the supine or side-lying position. The researcher will perform this application by wearing gloves. Wearing gloves will reduce the therapeutic interaction with the patient. Since applying pressure or circular rubbing movements to patients may enter the area where other meridians pass and create a different effect, it will be waited for 2 minutes without applying any pressure or rubbing movements on the bone protrusions where the meridian does not pass and where there are no active pressure points. The application will be determined to be approximately 2 cm away from the acupressure points. The application will again be done manually with the thumb. Each application will take approximately 18 minutes. 4 sessions of application and a total of 9 measurements will be made to the patients.
Eligibility Criteria
You may qualify if:
- Have received intensive care treatment for at least 48 hours,
- Are 18 years of age or older,
- Have a Glasgow Coma Scale score of \>13,
- Can speak and write in Turkish,
- Have no psychiatric diagnosis,
- Have no communication problems,
- Have a VAS score of ≥1,
- Have a mean arterial pressure of ≥65,
- Have SpO2 of ≥85.
You may not qualify if:
- Have previously received acupressure treatment,
- Have ulcers, necrotic tissue and signs and symptoms of infection at the points where pressure will be applied,
- Have used antihypertensives, beta-blockers and similar medications,
- Have sedation,
- Have respiratory support from the device,
- Have inotropic treatment (dopamine, steradin and others),
- Have analgesic treatment in their routine treatment will not be included in the study.
- Patients who were discharged during the study,
- Patients who died during the study,
- Patients who wanted to leave the study,
- Patients who started receiving sedation during the application,
- Patients who added antihypertensive, beta-blocker and similar drugs to their routine treatment during the application,
- Patients who received inotropic treatment (dopamine, steradin and others) during the application,
- Patients who started receiving analgesia treatment during the application,
- Patients who developed ulcers, necrotic tissue and infection at the points where pressure will be applied during the application,
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Ozlem Canbolat
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Gazi University
Study Record Dates
First Submitted
May 20, 2025
First Posted
May 29, 2025
Study Start
May 1, 2025
Primary Completion
December 31, 2025
Study Completion
January 31, 2026
Last Updated
March 19, 2026
Record last verified: 2026-03